Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.

Verheugt, FW; Clemmensen, P; Mehran, R; Agewall, S; Pocock, SJ; Goldstein, S; Torp-Pedersen, C; Simoons, ML; Borer, JS; Khder, YM; +6 more...Burton, P; Deliargyris, E; McMurray, JJ; Berkowitz, SD; Stough, WG; Zannad, F and (2013) Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. European heart journal, 34 (22). pp. 1621-1629. ISSN 0195-668X DOI: 10.1093/eurheartj/eht013
Copy
Item Type Article
Keywords myocardial-infarction, antiplatelet therapy, phase-ii, receptor, antagonist, clinical-outcomes, double-blind, intervention, clopidogrel, prasugrel, tolerability
ISI 320119600007
Date Deposited 29 Jul 2013 19:07

Explore Further

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads